Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1331 | GPR56 Blocking Peptide (AC1331) | 250 µg |
GPR56 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1332 | GAD65 Blocking Peptide (AC1332) | 250 µg |
GAD65 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1333 | Nurr1 Blocking Peptide (AC1333) | 250 µg |
Nurr1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1334 | DRP1 Blocking Peptide (AC1334) | 250 µg |
DRP1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg |
Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1336 | Estrogen Receptor alpha Blocking Peptide (AC1336) | 250 µg |
Estrogen Receptor alpha Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1337 | Neurochondrin Blocking Peptide (AC1337) | 250 µg |
Neurochondrin Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1338 | Dopamine Receptor D1 Blocking Peptide (AC1338) | 250 µg |
Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg |
MRAP2 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1340 | PDE7A Blocking Peptide (AC1340) | 250 µg |
PDE7A Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1341 | Pax2 Blocking Peptide (AC1341) | 250 µg |
Pax2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1342 | ORP150 Blocking Peptide (AC1342) | 250 µg |
ORP150 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg |
GIRK1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1344 | Olig2 Blocking Peptide (AC1344) | 250 µg |
Olig2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1345 | DISC1 Blocking Peptide (AC1345) | 250 µg |
DISC1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.